Pioglitazone Hydrochloride

Overview

Pioglitazone Hydrochloride is a thiazolidinedione-class antihyperglycemic agent that improves insulin sensitivity in patients with type 2 diabetes. It acts as a selective agonist for the peroxisome proliferator-activated receptor gamma (PPAR-γ), which is involved in the regulation of glucose and lipid metabolism.

API suppliers (23)

Suppliers of Pioglitazone Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV1 active DMF
• USV PRIVATE LTD1 active DMF
• Wockhardt LimitedIndia1 active DMF
• Wockhardt LimitedIndia1 active DMF
• USV PRIVATE LTD1 active DMF
• TAPI NL BV1 active DMF
• USV PRIVATE LTD1 active DMF
• TAPI NL BV1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• TAPI NL BV1 active DMF
• Wockhardt LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• USV PRIVATE LTD1 active DMF
• TAPI NL BV1 active DMF
• Wockhardt LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF
• Hetero Labs LimitedIndia
• Dr. Reddy's Laboratories Ltd.India
• MOREPEN LABORATORIES LTDIndia
• ERREGIERRE SPAItaly
• AARTI DRUGS LTDIndia
• Lupin LimitedIndia

Chemical identity

IUPAC name

5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

Canonical SMILES

CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3

InChIKey

HYAFETHFCAUJAY-UHFFFAOYSA-N

Therapeutic areas